[Ed. Note – This article does not meet our new editorial guidelines, nor does the company profiled meet our investment criteria. Both will be removed from the site in the future.]

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) is a New York-based biotherapeutics company that develops and commercializes drugs for the treatment of cancer and renal diseases. Recently, Keryx stock soared to a new 52-week high despite launching any new drug in the market.… Read more